ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Licorice Root Extract and Pomegranate Juice on Atherosclerotic Parameters in Diabetic Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00428532
Recruitment Status : Unknown
Verified January 2007 by HaEmek Medical Center, Israel.
Recruitment status was:  Recruiting
First Posted : January 30, 2007
Last Update Posted : May 8, 2007
Sponsor:
Information provided by:
HaEmek Medical Center, Israel

Brief Summary:
The study will check whether taking 100 mg of licorice root extract or 250 cc of pomegranate juice daily by men with diabetes mellitus who are non-smokers and already treated with statins decreases the risk of developing atherosclerosis. The hypothesis of the study is that natural anti-oxidants (such as licorice root extract and pomegranate juice), by scavenging free radicals, retard and may even reverse atherosclerosis.

Condition or disease Intervention/treatment Phase
Diabetes Mellitus Atherosclerosis Drug: Licorice root extract or Pomegranate juice Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : March 2007
Estimated Study Completion Date : August 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Atherosclerosis





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male
  • Diabetes Mellitus

Exclusion Criteria:

  • Younger than 18
  • Smoker
  • Receiving Fibrates

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00428532


Contacts
Contact: Wasseem Rock, MD 972-547866896 wasseem_rock@yahoo.com

Locations
Israel
HaEmek MC Recruiting
Afula, Israel
Contact: Wasseem Rock, MD    0547-866896    wasseem_rock@yahoo.com   
Principal Investigator: Wasseem Rock, MD         
Sponsors and Collaborators
HaEmek Medical Center, Israel
Investigators
Principal Investigator: Wasseem Rock, MD Ha'Emek Medical Center

ClinicalTrials.gov Identifier: NCT00428532     History of Changes
Other Study ID Numbers: 009-07-EMC
First Posted: January 30, 2007    Key Record Dates
Last Update Posted: May 8, 2007
Last Verified: January 2007

Additional relevant MeSH terms:
Diabetes Mellitus
Atherosclerosis
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases